LAVAL, Quebec, Jan. 30, 2017 /CNW/ -- Valeant Pharmaceuticals
International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the
"Company") today announced that it plans to hold a conference call
and live webcast on Tuesday, February 28,
2017 at 8:00 a.m. ET. The
Company will discuss fourth quarter and full year 2016 financial
results, and announce 2017 guidance during the presentation.
Related materials will be made available on the investor relations
portion of the corporate website before the start of the conference
call.
Conference Call Details
Date
|
Tuesday, February 28,
2017
|
Time
|
8:00 a.m.
ET
|
Webcast
|
http://ir.valeant.com/events-and-presentations
|
Participant Event
Dial-in
|
(877) 876-8393 (North
America)
|
|
(443) 961-0178
(International)
|
Participant
Passcode
|
63999208
|
Replay
Dial-in
|
(855) 859-2056 (North
America)
|
|
(404) 537-3406
(International)
|
Replay
Passcode
|
63999208 (replay
available until 03/31/2017)
|
About Valeant
Valeant Pharmaceuticals International,
Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical
company that develops, manufactures and markets a broad range of
pharmaceutical products primarily in the areas of dermatology,
gastrointestinal disorders, eye health, neurology and branded
generics. More information about Valeant can be found at
www.valeant.com.
Contact Information:
Elif
McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)
Media:
Renée Soto or
Chris
Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/valeant-to-hold-conference-call-to-present-fourth-quarter-and-full-year-2016-results-and-announce-2017-guidance-300398963.html
SOURCE Valeant Pharmaceuticals International, Inc.